IMNM
Immunome·NASDAQ
--
--(--)
--
--(--)
5.13 / 10
Netural
IMNM enjoys outstanding fund-flow dynamics (8.07/10), marked by positive trends in block, large, and extra-large inflows, despite minor negative signals in small and medium flows. Analyst sentiment is bullish but thin, with one Buy report and no sell-side skepticism. This combination of robust capital inflows and limited analyst coverage underscores the importance of monitoring both liquidity shifts and forthcoming research updates.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-15
InstitutionWedbush
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of IMNM?
- IMNM holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.13/10 (Netural).
